Medium urgency

Schedules of Controlled Substances: Rescheduling of Marijuana

Detected July 5, 2026 · in Cannabis & Hemp Operators

DEA proposes rescheduling marijuana to Schedule III, with a hearing starting June 29, 2026. This could reduce tax burdens and research restrictions but imposes new FDA compliance requirements.

Aforeworn detected this change in the Cannabis & Hemp Operators space on July 5, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Cannabis cultivators, dispensaries, processors, and hemp-derived THC brands should confirm how it applies to their specific situation before acting. There is a time constraint attached: June 29, 2026 (hearing start date). Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Cannabis & Hemp Operators continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

Marijuana proposed to move from Schedule I to Schedule III under the Controlled Substances Act

Who it affects

Cannabis cultivators, dispensaries, processors, and hemp-derived THC brands

What you must do

Monitor hearing outcomes and prepare for potential IRS Section 280E tax relief and FDA compliance obligations

Deadline

June 29, 2026 (hearing start date)

Source: https://www.federalregister.gov/documents/2026/04/28/2026-08177/schedules-of-controlled-substances-rescheduling-of-marijuana

Never miss a change like this again

Aforeworn watches Cannabis & Hemp Operators around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Cannabis & Hemp Operators